The effects of β/A4-amyloid and its fragments on calcium homeostasis, glial fibrillary acidic protein and S100β staining, morphology and survival of cultured hippocampal astrocytes

Neuroscience

Volumn 85, Issue 4, 1998, Pages 1151-1160

  Meske, V ^a   Hamker, U ^a   Albert, F ^a   Ohm, T G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

amyloid; Alzheimer's disease; Astrocytes; Calcium; cAMP; GFAP; S100

Indexed keywords

AMYLOID; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CALCIUM METABOLISM; CELL SURVIVAL; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BUCLADESINE; CALCIUM; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; S100 PROTEINS;

EID: 0032144457     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00008-6     Document Type: Article

References (52)

1. 1. Arendt T., Schindler C. and Brückner M. K. (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein I4 allele. J. Neurosci. 17, 516-529.
2. 2. Arispe N., Pollard H. B. and Rojas E. (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc. natn. Acad. Sci. U.S.A. 90, 10573-10577.
3. 3. Arispe N., Rojas E. and Pollard H. B. (1993) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. natn. Acad. Sci. U.S.A. 90, 567-571.
4. 4. Barger S. W., Fiscus R. R., Ruth P., Hofmann F. and Mattson M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of beta-amyloid precursor. J. Neurochem. 64, 2087-2096.
5. 5. Barger S. W. and Vaneldik L. J. (1992) S100beta stimulates calcium fluxes in glial and neuronal cells. J. biol. Chem. 267, 9689-9694.
6. 6. Barrow C. J. and Zagorski M. G. (1991) Solution structures of beta peptide and its constituent fragments - relation to amyloid deposition. Science 253, 179-182.
7. 7. Behl C., Davis J. B., Lesley R. and Schubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827.
8. 8. Coleman P. D. (ed.) (1992) Special Issue. Neurobiology of Aging, Vol. 13, No. 5.
9. 9. Corder E. H., Saunders A. M. and Strittmatter W. J. (1995) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45, 1323-1328.
10. 10. Cotman C. W., Pike C. J. and Copani A. (1992) Beta-amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging 13, 587-590.
11. 11. DeWitt D. A., Richey P. L., Praprotnik D., Silver J. and Perry G. (1994) Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Res. 656, 205-209.
12. 12. Flood J. F., Morley J. E. and Roberts E. (1991) Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 88, 3363-3366.
13. 13. Freshney R. I. (1987) Culture of Animal Cells - A Manual of Basic Technique. Alan R. Liss, New York.
14. 14. Goldman J. E. and Abramson B. (1990) Cyclic AMP-induced shape changes of astrocytes are accompanied by rapid depolymerization of actin. Brain Res. 528, 189-196.
15. 15. Griffin W. S. T., Stanley L. C. and Ling C. (1989) Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 86, 7611-7615.
16. 2+ indicators with greatly improved fluorescence properties. J. biol. Chem. 260, 3440.
17. 17. Harrigan M. R., Kunkel D. D., Nguyen L. B. and Malouf A. T. (1995) Beta amyloid is neurotoxic in hippocampal slice cultures. Neurobiol. Aging 16, 779-789.
18. 18. Hollosi M., Otvos L. Jr, Kajtar J., Percel A. and Lee V. M. (1989) Is amyloid deposition in Alzheimer's disease anteceded by an environment-induced double conformational transition? Pept. Res. 2, 109-113.
19. 19. Jarrett J. T., Berger E. P. and Lansbury P. T. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
20. 20. Jorgensen O. S., Brooksbank B. W. L. and Balázs R. (1990) Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease. J. neurol. Sci. 98, 63-79.
21. 21. Kirschner D. A., Inouye H., Duffy L. K., Sinclair A., Lind M. and Selkoe D. J. (1987) Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. natn. Acad. Sci. U.S.A. 84, 6953-6957.
22. 2+ concentration in cultured rat microglia. Eur. J. Pharmac. 288, 125-130.
23. 23. Labourdette G. and Mandel P. (1978) S-100 protein in monolayer cultures of glial cells: basal level in primary and secondary cultures. Biochem. biophys. Res. Commun. 85, 1307-1313.
24. 24. Labourdette G. and Mandel P. (1980) Effect of norepinephrine and dibutyryl cyclic AMP on S-100 protein level in C6 glioma cells. Biochem. biophys. Res. Commun. 96, 1702-1709.
25. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
26. 26. Mattson M. P. and Barger S. W. (1993) Roles for calcium signaling in structural plasticity and pathology in the hippocampal system. Hippocampus 3 Spec. No., 73-87.
27. 27. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I. and Rydel R. E. (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
28. 28. Miyazaki K., Hasegawa M., Funahashi K. and Umeda M. (1993) A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor [see comments]. Nature 362, 839-841.
29. 29. Murrell J., Farlow M., Ghetti B. and Benson M. D. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
30. 30. Ohm T. G., Muller H., Braak H. and Bohl J. (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 64, 209-217.
31. 31. Paradiso A. M., Cheng E. H. and Boucher R. C. (1991) Effects of bradykinin on intracellular calcium regulation in human ciliated airway epithelium. Am. J. Physiol. 261, L63-L69.
32. 32. Pena L. A., Brecher C. W. and Marshak D. R. (1995) Beta-amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures. Brain Res. molec. Brain Res. 34, 118-126.
33. 33. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G. and Cotman C. W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
34. 34. Pike C. J., Cummings B. J. and Cotman C. W. (1992) Beta-amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuro Report 3, 769-772.
35. 35. Pike C. J., Cummings B. J., Monzavi R. and Cotman C. W. (1994) Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63, 517-531.
36. 36. Pike C. J., Walencewicz Wasserman A. J., Kosmoski J., Cribbs D. H., Glabe C. and Cotman C. W. (1995) Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
37. 37. Pike C. J., Walencewicz A. J., Glabe C. G. and Cotman C. W. (1991) In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
38. 38. Pitas R. E., Boyles J. K., Lee S. H., Foss D. and Mahley R. W. (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. biophys. Acta 917, 148-161.
39. 39. Poirier J., Baccichet A., Dea D. and Gauthier S. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90.
40. 40. Raju T. R. and Dahl D. (1982) Immunofluorescence staining of cultured neurons: a comparative study using tetanus toxin and neurofilament antisera. Brain Res. 248, 196-200.
41. 41. Salinero O., Moreno Flores M. T., Ceballos M. L. and Wandosell F. (1997) Beta-amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. J. Neurosci. Res. 47, 216-223.
42. 42. Sandbrink R., Masters C. L. and Beyreuther K. (1996) APP gene family. Alternative splicing generates functionally related isoforms. Ann. N. Y. Acad. Sci. 777, 281-287.
43. 43. Shen C. L., Scott G. L., Merchant F. and Murphy R. M. (1993) Light scattering analysis of fibril growth from the amino-terminal fragment beta (1-28) of beta-amyloid peptide. Biophys. J. 65, 2383-2395.
44. 44. Sisodia S. S. and Price D. L. (1995) Role of the beta-amyloid protein in Alzheimer's disease. Fedn Proc. Fedn Am. Socs exp. Biol. 9, 366-370.
45. 45. Soto C. and Frangione B. (1995) Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neurosci. Lett. 186, 115-118.
46. 46. Strittmatter W. J. and Roses A. D. (1995) Apolipoprotein E and Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 92, 4725-4727.
47. 47. Takadera T., Sakura N., Mohri T. and Hashimoto T. (1993) Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention, Neurosci. Lett. 161, 41-44.
48. 48. Terry R. D., Masliah E. and Salmon D. P. (1991) Physical basis of cognitive alterations in Alzheimer's disease - synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
49. 49. Tierney M. C., Fisher R. H. and Lewis A. J. (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38, 359-364.
50. 50. Van Huynh T., Cole G., Katzman R., Huang K. P. and Saitoh T. (1989) Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts. Archs Neurol. 46, 1195-1199.
51. 51. West H. L., Rebeck G. W. and Hyman B. T. (1994) Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci. Lett. 175, 46-48.
52. 52. Yankner B. A., Duffy L. K. and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta-protein - reversal by tachykinin neuropeptides. Science 250, 279-282.